Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides H Kang, R DeLong, MH Fisher, RL Juliano Pharmaceutical research 22 (12), 2099-2106, 2005 | 253 | 2005 |
Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules RK DeLong, CM Reynolds, Y Malcolm, A Schaeffer, T Severs, ... Nanotechnology, science and applications 3, 53, 2010 | 199 | 2010 |
Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery R Delong, K Stephenson, T Loftus, M Fisher, S Alahari, A Nolting, ... Journal of pharmaceutical sciences 86 (6), 762-764, 1997 | 181 | 1997 |
Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5'cholesterol-conjugated phosphorothioate antisense oligonucleotides. SK Alahari, NM Dean, MH Fisher, R Delong, M Manoharan, KL Tivel, ... Molecular pharmacology 50 (4), 808-819, 1996 | 141 | 1996 |
Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression SK Alahari, R DeLong, MH Fisher, NM Dean, P Viliet, RL Juliano Journal of Pharmacology and Experimental Therapeutics 286 (1), 419-428, 1998 | 106 | 1998 |
Protamine-mediated DNA coating remarkably improves bombardment transformation efficiency in plant cells E Sivamani, RK DeLong, R Qu Plant cell reports 28 (2), 213-221, 2009 | 72 | 2009 |
Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice RK DeLong, A Nolting, M Fisher, Q Chen, E Wickstrom, M Kligshteyn, ... Antisense and Nucleic Acid Drug Development 7 (2), 71-77, 1997 | 65 | 1997 |
Characterization and performance of nucleic acid nanoparticles combined with protamine and gold RK DeLong, U Akhtar, M Sallee, B Parker, S Barber, J Zhang, M Craig, ... Biomaterials 30 (32), 6451-6459, 2009 | 57 | 2009 |
Towards biosensors based on conducting polymer nanowires SB Tolani, M Craig, RK DeLong, K Ghosh, AK Wanekaya Analytical and bioanalytical chemistry 393 (4), 1225-1231, 2009 | 54 | 2009 |
Structural characterization and biological evaluation of small interfering RNAs containing cyclohexenyl nucleosides K Nauwelaerts, M Fisher, M Froeyen, E Lescrinier, A Van Aerschot, D Xu, ... Journal of the American Chemical Society 129 (30), 9340-9348, 2007 | 47 | 2007 |
Morphology of hydrothermally synthesized ZnO nanoparticles tethered to carbon nanotubes affects electrocatalytic activity for H2O2 detection MB Wayu, RT Spidle, T Devkota, AK Deb, RK Delong, KC Ghosh, ... Electrochimica acta 97, 99-104, 2013 | 46 | 2013 |
Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine PS Miller, G Bi, SA Kipp, V Fok, RK DeLong Nucleic acids research 24 (4), 730-736, 1996 | 45 | 1996 |
Novel cationic amphiphiles as delivery agents for antisense oligonucleotides RK DeLong, H Yoo, SK Alahari, M Fisher, SM Short, SH Kang, R Kole, ... Nucleic acids research 27 (16), 3334-3341, 1999 | 42 | 1999 |
Probing the interaction at the nano–bio interface using raman spectroscopy: ZnO nanoparticles and adenosine triphosphate biomolecules A Bhaumik, AM Shearin, R Delong, A Wanekaya, K Ghosh The Journal of Physical Chemistry C 118 (32), 18631-18639, 2014 | 39 | 2014 |
mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I: C RNA J Reyes-Reveles, R Sedaghat-Herati, DR Gilley, AM Schaeffer, KC Ghosh, ... Biomacromolecules 14 (11), 4108-4115, 2013 | 32 | 2013 |
Zinc oxide nanoparticle–poly I: C RNA complexes: Implication as therapeutics against experimental melanoma M Ramani, MC Mudge, RT Morris, Y Zhang, SA Warcholek, MN Hurst, ... Molecular Pharmaceutics 14 (3), 614-625, 2017 | 29 | 2017 |
Interaction of MnO and ZnO nanomaterials with biomedically important proteins and cells H Gann, G Glaspell, R Garrad, A Wanekaya, K Ghosh, L Cillessen, ... Journal of Biomedical Nanotechnology 6 (1), 37-42, 2010 | 28 | 2010 |
Hepatic distribution and clearance of antisense oligonucleotides in the isolated perfused rat liver A Nolting, RK DeLong, MH Fisher, E Wickstrom, GM Pollack, RL Juliano, ... Pharmaceutical research 14 (4), 516-521, 1997 | 23 | 1997 |
pDNA bioparticles: comparative heterogeneity, surface, binding, and activity analyses P Medberry, S Dennis, T Van Hecke, RK DeLong Biochemical and biophysical research communications 319 (2), 426-432, 2004 | 20 | 2004 |
Enzyme and cancer cell selectivity of nanoparticles: inhibition of 3-D metastatic phenotype and experimental melanoma by zinc oxide RK DeLong, JA Mitchell, RT Morris, J Comer, MN Hurst, K Ghosh, ... Journal of Biomedical Nanotechnology 13 (2), 221-231, 2017 | 19 | 2017 |